Myomo, Inc. (MYO) Analysts See $-0.19 EPS

July 14, 2018 - By Alicia Butler

Analysts expect Myomo, Inc. (NYSEAMERICAN:MYO) to report $-0.19 EPS on August, 13.They anticipate $0.87 EPS change or 82.08 % from last quarter’s $-1.06 EPS. After having $-0.20 EPS previously, Myomo, Inc.’s analysts see -5.00 % EPS growth. The stock increased 0.88% or $0.02 during the last trading session, reaching $2.28. About 146,248 shares traded. Myomo, Inc. (NYSEAMERICAN:MYO) has 0.00% since July 14, 2017 and is . It has underperformed by 12.57% the S&P500.

Myomo, Inc., a commercial stage medical robotics Company, provides expanded mobility solutions for patients suffering from neurological disorders and upper limb paralysis in the United States. The company has market cap of $28.30 million. The firm develops and markets MyoPro, a myoelectric elbow/wrist/hand orthosis that supports an impaired hands and arms of individuals due to a brachial plexus injury, stroke, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, and other upper limb neuromuscular deficits. It currently has negative earnings.

Myomo, Inc. (NYSEAMERICAN:MYO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.